Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
PR Newswire —
CHMP recommendation marks major step toward first authorised treatment for WHIM syndrome in Europe Final decision expected from the European Commission in Q2 2026 Partnership with X4 Pharmaceuticals for Norgine-led commercialisation in Europe AMSTERDAM, Feb. 27, 2026 /PRNewswire/ --...